You are here
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
Camilo Rojas, MithunRaje, TakashiTsukamoto, BarbaraS.Slusher
European Journal of Pharmacology, Volume 722, 5 January 2014, Pages 26–37
Editors' comments: Dr. A.Snegovoy
Nausea and vomiting are still one of the most adverse events occurring during chemotherapy. Currently, prevention of nausea and vomiting during chemotherapy drugs includes receptor 5-HT3 antagonists and receptor NK1 antagonist.
Despite these successes, it is necessary to conduct further studies in this field. A better understanding of the mechanisms of the pharmacological agents used to prevent nausea and vomiting will lead to a more efficient use of the existing regimens.